|
Volumn 50, Issue 3, 2002, Pages 179-185
|
Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate
a,c a,c b,c a,c a,c c a,c a,c |
Author keywords
MDR; Megestrol acetate; P gp; Vinblastine
|
Indexed keywords
CORTICOTROPIN;
HYDROCORTISONE;
MEGESTROL ACETATE;
VINBLASTINE;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOTROPIN BLOOD LEVEL;
CULTURE MEDIUM;
DIARRHEA;
DISEASE SEVERITY;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSPNEA;
FEMALE;
HUMAN;
HYDROCORTISONE BLOOD LEVEL;
HYPOPHYSIS ADRENAL SYSTEM;
INFECTION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
MAXIMUM TOLERATED DOSE;
NAUSEA;
NEUROPATHY;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
SOLID TUMOR;
THROMBOSIS;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
MALE;
MEGESTROL ACETATE;
MIDDLE AGED;
NEOPLASMS;
PITUITARY-ADRENAL SYSTEM;
VINBLASTINE;
|
EID: 0036047665
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s00280-002-0484-9 Document Type: Article |
Times cited : (8)
|
References (36)
|